Iridex (IRIX) Net Cash Flow Growth (1y) (2012 - 2026)
Iridex (IRIX) Net Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | 76.43% |
| 10 | Iridex | 15.45 Mn | 10.86 Mn | 4.74 Mn | -129.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -129.45% |
| Jan 3, 2026 | 131.13% |
| Sep 27, 2025 | -380.08% |
| Jun 28, 2025 | 68.02% |
| Mar 29, 2025 | 395.52% |
| Dec 28, 2024 | -62.42% |
| Sep 28, 2024 | 86.71% |
| Jun 29, 2024 | -8.69% |
| Mar 30, 2024 | 42.05% |
| Dec 30, 2023 | 46.08% |
| Sep 30, 2023 | 13.75% |
| Jul 1, 2023 | 55.52% |
| Apr 1, 2023 | 12.95% |
| Dec 31, 2022 | -113.10% |
| Apr 2, 2022 | -120.08% |
| Apr 3, 2021 | 1,170.45% |
| Sep 26, 2020 | 113.84% |
| Jun 27, 2020 | 132.78% |
| Mar 28, 2020 | 62.42% |
| Dec 28, 2019 | 89.00% |